Bio Island Cherry Fizz Multi Effervescent For Kids

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

pyridoxine hydrochloride, Quantity: 0.864 mg (Equivalent: pyridoxine, Qty 700 microgram); retinol palmitate, Quantity: 5.33 mg (Equivalent: vitamin A, Qty 218 RE/microgram); Biotin, Quantity: 25 microgram; calcium pantothenate, Quantity: 3.38 mg (Equivalent: pantothenic acid, Qty 3 mg); potassium iodide, Quantity: 0.098 mg (Equivalent: iodine, Qty 75 microgram); ascorbic acid, Quantity: 40 mg; nicotinamide, Quantity: 8 mg; riboflavin sodium phosphate, Quantity: 0.995 mg (Equivalent: riboflavin, Qty 700 microgram); manganese sulfate monohydrate, Quantity: 3.125 mg (Equivalent: manganese, Qty 1 mg); chromic chloride hexahydrate, Quantity: 0.103 mg (Equivalent: chromium, Qty 20 microgram); phytomenadione, Quantity: 37.5 microgram; dl-alpha-tocopheryl acetate, Quantity: 17.88 mg (Equivalent: dl-alpha-tocopherol, Qty 6 mg); magnesium carbonate hydrate, Quantity: 240 mg (Equivalent: magnesium, Qty 60 mg); colecalciferol, Quantity: 300 IU; cyanocobalamin, Quantity: 1.3 microgram; calcium carbonate, Quantity: 304 mg (Equivalent: calcium, Qty 120 mg); thiamine hydrochloride, Quantity: 0.802 mg (Equivalent: thiamine, Qty 600 microgram); folic acid, Quantity: 100 microgram; ferrous gluconate dihydrate, Quantity: 18.34 mg (Equivalent: iron, Qty 2.1 mg); zinc citrate trihydrate, Quantity: 15.748 mg (Equivalent: zinc, Qty 5 mg)

Disponible depuis:

JBX Pty Ltd

DCI (Dénomination commune internationale):

Ascorbic acid,Biotin,chromic chloride hexahydrate,colecalciferol,Calcium carbonate,Calcium pantothenate,Cyanocobalamin,dl-alpha-

forme pharmaceutique:

Tablet, effervescent

Composition:

Excipient Ingredients: calcium phosphate; sodium bicarbonate; maltodextrin; silicon dioxide; sucrose; sucralose; purified water; beetroot; mannitol; liquid glucose; dl-alpha-tocopherol; macrogol 4000; Acacia; starch sodium octenyl succinate; citric acid; maize starch; Flavour

Mode d'administration:

Oral

indications thérapeutiques:

Maintain/support healthy growth and development

Descriptif du produit:

Visual Identification: ;

Statut de autorisation:

Licence status A

Date de l'autorisation:

2015-11-05